Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Clin Genet ; 86(4): 367-72, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24117009

ABSTRACT

Aminoacylase 1 (ACY1) deficiency is a rare inborn error of metabolism of which less than 20 observations have been described. Patients exhibit urinary excretion of specific N-acetyl amino acids and manifest a heterogeneous clinical spectrum including intellectual disability, motor delay, seizures, moderate to severe mental retardation, absent speech, growth delay, muscular hypotonia and autistic features. Here, we report the case of ACY1 enzyme deficiency in a 6-year-old girl presenting severe intellectual disability, motor retardation, absence of spontaneous locomotor activity and severe speech delay. Urinary excretion of N-acetylated amino acids was present. Mutational analysis of ACY1 gene identified the new homozygous c.1001_1001+5del6 mutation, which alters the mRNA transcription leading to exon 13 skipping and inclusion of a premature stop codon (p.Lys308Glufs*7). A quantitative fluorescent multiplex-polymerase chain reaction (QFM-PCR) assay has been set up and confirmed homozygosity of the mutation in the patient's DNA. Biochemical analysis showed absence of ACY1 enzyme activity in the patient's fibroblasts. The structure of the mutated protein has been defined by homology modeling (HM). Our data endorse the hypothesis of a link between this inborn error of metabolism and the neurological manifestations observed in patients with ACY1 deficiency.


Subject(s)
Amidohydrolases/deficiency , Amino Acid Metabolism, Inborn Errors/genetics , Exons/genetics , Amidohydrolases/biosynthesis , Amidohydrolases/genetics , Amino Acid Metabolism, Inborn Errors/pathology , Child , Female , Fibroblasts/metabolism , Humans , RNA, Messenger/biosynthesis , RNA, Messenger/genetics
2.
Gene ; 493(2): 228-34, 2012 Feb 10.
Article in English | MEDLINE | ID: mdl-22173106

ABSTRACT

Carbamoyl Phosphate Synthetase 1 deficiency (CPS1D) is a rare autosomal recessive urea cycle disorder, potentially leading to lethal hyperammonemia. Based on the age of onset, there are two distinct phenotypes: neonatal and late form. The CPS1 enzyme, located in the mitochondrial matrix of hepatocytes and epithelial cells of intestinal mucosa, is encoded by the CPS1 gene. At present more than 220 clear-cut genetic lesions leading to CPS1D have been reported. As most of them are private mutations diagnosis is complicated. Here we report an overview of the main clinical findings and biochemical and molecular data of 13 CPS1D Italian patients. In two of them, one with the neonatal form and one with the late form, cadaveric auxiliary liver transplant was performed. Mutation analysis in these patients identified 17 genetic lesions, 9 of which were new confirming their "private" nature. Seven of the newly identified mutations were missense/nonsense changes. In order to study their protein level effects, we performed an in silico analysis whose results indicate that the amino acid substitutions occur at evolutionary conserved positions and affect residues necessary for enzyme stability or function.


Subject(s)
Carbamoyl-Phosphate Synthase (Ammonia)/genetics , Carbamoyl-Phosphate Synthase I Deficiency Disease/genetics , Adolescent , Adult , Carbamoyl-Phosphate Synthase I Deficiency Disease/diagnosis , Child, Preschool , Cohort Studies , Female , Humans , Infant , Infant, Newborn , Italy , Male , Mutation
3.
Neurol Sci ; 28(6): 328-30, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18175080

ABSTRACT

Short-chain-acyl-CoA-dehydrogenase (SCAD) deficiency is an inborn error of mitochondrial fatty acid metabolism caused by rare mutations as well as common susceptibility variations in the SCAD gene. We describe the case of a 23-year-old male patient who had growth and mental retardation, recurrent vomiting, fever and seizures since infancy. Urinary gas chromatography and (1)H-nuclear magnetic resonance showed elevated levels of ethylmalonic acid. Serum concentrations of acylcarnitine, especially butyrylcarnitine (C4), were abnormally high. A homozygous variant allele of the SCAD gene, 625G>A, was detected. The patient broadens the clinical phenotype of SCAD deficiency and underlines the difficulty of diagnosis. The limited number of patients described may be the result of underdiagnosis.


Subject(s)
Butyryl-CoA Dehydrogenase/deficiency , Magnetic Resonance Spectroscopy/methods , Metabolism, Inborn Errors/blood , Adult , Butyryl-CoA Dehydrogenase/genetics , Carnitine/analogs & derivatives , Carnitine/blood , Chromatography, Gas/methods , Humans , Male , Metabolism, Inborn Errors/diagnosis , Metabolism, Inborn Errors/genetics
4.
Clin Genet ; 69(1): 72-6, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16451139

ABSTRACT

Genetic and biochemical prenatal diagnosis was performed at 11 weeks of gestation in a family with a proband affected by mut methylmalonic aciduria (MMA) and homozygotes for the MUT gene c.643G>A (p.Gly215Ser) mutation. Both chorionic villus and amniotic fluid samples were used. The presence of high levels of methylmalonic acid and propionylcarnitine determined by gas chromatography/mass spectrometry and LC/MS/MS analysis, respectively, and the identification of the p.Gly215Ser at a homozygous level in foetal DNA allowed a certain, rapid and early diagnosis. To our knowledge, this is the first mut MMA prenatal diagnosis carried out by genetic and biochemical approach.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Methylmalonic Acid/urine , Prenatal Diagnosis/methods , Amino Acid Metabolism, Inborn Errors/genetics , Base Sequence , DNA Mutational Analysis , Family Health , Female , Gestational Age , Humans , Molecular Sequence Data , Pregnancy
5.
J Inherit Metab Dis ; 28(5): 801-2, 2005.
Article in English | MEDLINE | ID: mdl-16151916

ABSTRACT

We report the two first prenatal diagnoses in an Italian family with a proband affected by neonatal carbamyl-phosphate synthetase I deficiency in which molecular analysis identified V457G and Q810R amino acid substitutions. We performed a prenatal diagnosis on genomic DNA isolated from chorionic villus and amniotic fluid samples collected at 13 weeks of gestation. In the first pregnancy, the fetus was compound heterozygous for the mutations and termination of pregnancy was elected. The genetic lesions were also confirmed on genomic DNA isolated from the fetus's liver and skin fibroblasts. A few months later, we performed a second prenatal diagnosis in this family. The second fetus was heterozygous for the wild-type alleles. The pregnancy was continued and a girl was born at 41 weeks of gestation. We have confirmed the wild-type state on the baby's DNA.


Subject(s)
Carbamoyl-Phosphate Synthase (Ammonia)/deficiency , Pregnancy Complications , Prenatal Diagnosis/methods , Amniocentesis , Amniotic Fluid/metabolism , Biopsy , Chorionic Villi/metabolism , DNA Mutational Analysis , Female , Fibroblasts/metabolism , Heterozygote , Humans , Liver/embryology , Liver/enzymology , Liver/metabolism , Liver/pathology , Pregnancy , Sequence Analysis, DNA , Skin/metabolism , Time Factors
6.
Hum Mutat ; 22(4): 340-1, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12955727

ABSTRACT

Carbamyl Phosphate Synthetase I deficiency (CPSID) is a rare autosomal recessive urea cycle disorder usually characterized by potentially lethal neonatal hyperammonemia. The large (5215 bp) CPS1-cDNA, expressed only in liver and epithelial cells of intestinal mucosa, has been cloned. Until now the CPS1 genomic organization was unknown. Taking advantage of the phylogenetic lineage between the CPS1 gene of Homo sapiens and Rattus norvegicus, we determined the intron-exon organization of the human CPS1 gene. Starting from the ATG codon, the CPS I gene is organized in 38 exons spanning from 50bp to 200 bp. We also report the molecular studies on an Italian patient affected by neonatal CPSD. Two novel genetic lesions (c.1370T>G and c.2429A>G) that lead to the novel amino acid substitutions V457G and Q810R, and the known N1406T polymorphism, were detected in the patient's CPS1 RNA and in genomic DNA isolated from peripheral blood lymphocytes. The characterization of the CPS1 genomic organization will allow the identification of the genetic lesions of CPSD patients, the detection of carriers, better genetic counseling and a more certain, less invasive method of prenatal diagnosis.


Subject(s)
Amino Acid Substitution , Carbamoyl-Phosphate Synthase (Ammonia)/genetics , Carbamoyl-Phosphate Synthase I Deficiency Disease/genetics , Animals , Base Sequence , Exons , Female , Humans , Infant , Introns , Molecular Sequence Data , Point Mutation , Polymorphism, Genetic , RNA Splice Sites , Rats
7.
J Inherit Metab Dis ; 25(4): 328-30, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12227467

ABSTRACT

Mutation analysis performed on DNA from 6 Italian patients with partial biotinidase deficiency ascertained by newborn screening allowed the identification of two new mutations, c1211C > T (T404I) and a single base deletion c594delC. All patients were compound heterozygous for the D444H amino acid substitution showing that this mutation is also common in Italian patients affected by partial biotinidase deficiency.


Subject(s)
Amidohydrolases/deficiency , Mutation/genetics , Amino Acid Substitution/genetics , Biotinidase , DNA Mutational Analysis , Humans , Infant, Newborn , Italy , Neonatal Screening
8.
Am J Med Genet ; 111(1): 10-8, 2002 Jul 22.
Article in English | MEDLINE | ID: mdl-12124727

ABSTRACT

Holocarboxylase synthetase (HLCS) deficiency (HLCSD) is a rare autosomal recessive disorder of biotin metabolism. HLCS catalyzes the biotinylation of the four human biotin-dependent carboxylases. Using the newly available human genomic sequence, we report the map of HLCS genomic structure and the predicted exon/intron boundaries. Moreover, the molecular studies of four patients (two Italians, one Iranian, and one Australian) affected by HLCS deficiency are here reported. The clinical findings, the age of onset, and response to biotin treatment differed between our patients. The diagnosis was made by organic acid analysis and confirmed by enzymatic analysis in three patients. Six mutations in the HLCS gene were identified, including two novel (N511K and G582R) and four known missense mutations (L216R, R508W, V550M, and G581S). Five of the mutations are localized within the HLCS biotin-binding domain, whereas the L216R amino acid change is located in the N-terminal region outside of the putative biotin-binding domain. This mutation, previously reported in a heterozygous state, was detected for the first time in a patient with homozygous status. The patient's severe clinical phenotype and partial responsiveness to biotin support a genotype-phenotype correlation through the involvement of residues of the N-terminal region in a substrate specificity recognition or regulation of the HLCS enzyme.


Subject(s)
Carbon-Nitrogen Ligases/genetics , Holocarboxylase Synthetase Deficiency/genetics , Acidosis/enzymology , Acidosis/genetics , Acids/urine , Age of Onset , Amino Acid Substitution , Binding Sites , Biotin/therapeutic use , Biotinylation , Cells, Cultured , DNA Mutational Analysis , DNA, Complementary/genetics , Exons/genetics , Fatal Outcome , Genes , Genes, Recessive , Genotype , Holocarboxylase Synthetase Deficiency/blood , Holocarboxylase Synthetase Deficiency/drug therapy , Holocarboxylase Synthetase Deficiency/pathology , Humans , Infant , Intellectual Disability/enzymology , Intellectual Disability/genetics , Introns/genetics , Male , Mutation, Missense , Phenotype , Protein Structure, Tertiary , Restriction Mapping , Skin/pathology , Substrate Specificity
9.
Mol Genet Metab ; 73(3): 268-75, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11461194

ABSTRACT

3-Hydroxy-3-methylglutaric aciduria is a rare autosomal recessive inborn error of metabolism caused by deficiency of the mitochondrial enzyme 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL). Up to now only a few mutations have been reported in the HMGCL gene. We report the first Italian patient, a female who presented metabolic acidosis at 3 days of age and then 3 months later. Analysis of urinary organic acids showed the excretion of 3-hydroxy-3-methylglutaric acid, 3-methylglutaconic acid, 3-methylglutaric acid, and 3-hydroxyisovaleric acid. A defect of HMGCL activity was suspected and then confirmed on cultured skin fibroblasts. Brain RM showed a diffuse mild abnormality of cerebral white matter in the periventricular regions, and the single voxel proton MRI spectroscopy showed abnormal peaks. In the patient's full-length HMGCL-cDNA a new c286C > T transition that leads to the stop codon Q96X was detected at the homozygous level. This mutation, that gives rise to a truncated protein, was confirmed in the patient's and also her parents' genomic DNA. The severe genetic lesion identified in the patient, which is in contrast with the mild clinical phenotype, stresses the importance of early diagnosis and therapy in HMGCL deficiency.


Subject(s)
Codon, Nonsense , Meglutol/urine , Oxo-Acid-Lyases/genetics , Brain/pathology , Cells, Cultured , Child, Preschool , DNA, Complementary/metabolism , Female , Fibroblasts/metabolism , Humans , Italy , Magnetic Resonance Imaging , Male , Mothers , Pedigree , Polymerase Chain Reaction , RNA/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL